BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37633678)

  • 1. Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies.
    Fares AF; Li Y; Jiang M; Brown MC; Lam ACL; Aggarwal R; Schmid S; Leighl NB; Shepherd FA; Wang Z; Diao N; Wenzlaff AS; Xie J; Kohno T; Caporaso NE; Harris C; Ma H; Barnett MJ; Leal LF; Fernandez-Tardon G; Pérez-Ríos M; Davies MPA; Taylor F; Schöttker B; Brennan P; Zaridze D; Holcatova I; Lissowska J; Świątkowska B; Mates D; Savic M; Brenner H; Andrew A; Cox A; Field JK; Ruano-Ravina A; Shete SS; Tardon A; Wang Y; Le Marchand L; Reis RM; Schabath MB; Chen C; Shen H; Ryan BM; Landi MT; Shiraishi K; Zhang J; Schwartz AG; Tsao MS; Christiani DC; Yang P; Hung RJ; Xu W; Liu G
    Lancet Public Health; 2023 Sep; 8(9):e691-e700. PubMed ID: 37633678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis.
    Lee JJW; Kunaratnam V; Kim CJH; Pienkowski M; Hueniken K; Sahovaler A; Lam ACL; Davies JC; Brown CM; De Almeida JR; Huang SH; Waldron JN; Spreafico A; Hung RJ; Xu W; Goldstein DP; Liu G
    Cancer; 2023 Mar; 129(6):867-877. PubMed ID: 36653915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study to assess impact of smoking at diagnosis and quitting on 1-year survival for people with non-small cell lung cancer.
    Gemine RE; Ghosal R; Collier G; Parry D; Campbell I; Davies G; Davies K; Lewis KE;
    Lung Cancer; 2019 Mar; 129():1-7. PubMed ID: 30797485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediagnosis Smoking Cessation and Overall Survival Among Patients With Non-Small Cell Lung Cancer.
    Wang X; Romero-Gutierrez CW; Kothari J; Shafer A; Li Y; Christiani DC
    JAMA Netw Open; 2023 May; 6(5):e2311966. PubMed ID: 37145597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between body-mass index and overall survival in non-small cell lung cancer by sex, smoking status, and race: A pooled analysis of 20,937 International lung Cancer consortium (ILCCO) patients.
    Jiang M; Fares AF; Shepshelovich D; Yang P; Christiani D; Zhang J; Shiraishi K; Ryan BM; Chen C; Schwartz AG; Tardon A; Shete S; Schabath MB; Teare MD; Le Marchand L; Zhang ZF; Field JK; Brenner H; Diao N; Xie J; Kohno T; Harris CC; Wenzlaff AS; Fernandez-Tardon G; Ye Y; Taylor F; Wilkens LR; Davies M; Liu Y; Barnett MJ; Goodman GE; Morgenstern H; Holleczek B; Thomas S; Brown MC; Hung RJ; Xu W; Liu G
    Lung Cancer; 2021 Feb; 152():58-65. PubMed ID: 33352384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of smoking abstinence as a predictor for non-small-cell lung cancer survival in women.
    Ebbert JO; Williams BA; Sun Z; Aubry MC; Wampfler JA; Garces YI; Meyer RL; Yang P
    Lung Cancer; 2005 Feb; 47(2):165-72. PubMed ID: 15639715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Body Mass Index (BMI), BMI Change, and Overall Survival in Patients With SCLC and NSCLC: A Pooled Analysis of the International Lung Cancer Consortium.
    Shepshelovich D; Xu W; Lu L; Fares A; Yang P; Christiani D; Zhang J; Shiraishi K; Ryan BM; Chen C; Schwartz AG; Tardon A; Wu X; Schabath MB; Teare MD; Le Marchand L; Zhang ZF; Field JK; Brenner H; Diao N; Xie J; Kohno T; Harris CC; Wenzlaff AS; Fernandez-Tardon G; Ye Y; Taylor F; Wilkens LR; Davies M; Liu Y; Barnett MJ; Goodman GE; Morgenstern H; Holleczek B; Brown MC; Liu G; Hung RJ
    J Thorac Oncol; 2019 Sep; 14(9):1594-1607. PubMed ID: 31163278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological analysis of progression-free survival (PFS) and overall survival (OS) in non-small-cell lung cancer patients in Republic of Macedonia.
    Risteski M; Crvenkova S; Atanasov Z; Isjanovska R
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2013; 34(3):49-61. PubMed ID: 24566015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quitting smoking improves two-year survival after a diagnosis of non-small cell lung cancer.
    Gemine RE; Davies GR; Lanyon K; Rees SE; Campbell I; Lewis KE;
    Lung Cancer; 2023 Dec; 186():107388. PubMed ID: 37820539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality : A Prospective Cohort Study.
    Sheikh M; Mukeriya A; Shangina O; Brennan P; Zaridze D
    Ann Intern Med; 2021 Sep; 174(9):1232-1239. PubMed ID: 34310171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study.
    Luo YH; Luo L; Wampfler JA; Wang Y; Liu D; Chen YM; Adjei AA; Midthun DE; Yang P
    Lancet Oncol; 2019 Aug; 20(8):1098-1108. PubMed ID: 31255490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and Outcomes of Non-Small Cell Lung Cancer in South Korea.
    Jung HA; Lee DH; Lim SM; Yu H; Yoon S; Kim D; Kim KP; Jeong H; Doh H; Lim S; Kim J; Zhao X; Horsburgh D; Patel D; Kim JA; Toh KC
    JAMA Netw Open; 2024 Feb; 7(2):e2355331. PubMed ID: 38334998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proportion of Non-Small-Cell Lung Cancer Patients that Would Have Been Eligible for Lung Cancer Screening.
    Wu GX; Goldstein L; Kim JY; Raz DJ
    Clin Lung Cancer; 2016 Sep; 17(5):e131-e139. PubMed ID: 26872765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
    Bryant A; Cerfolio RJ
    Chest; 2007 Jul; 132(1):185-92. PubMed ID: 17573517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung Cancer.
    Popat S; Liu SV; Scheuer N; Gupta A; Hsu GG; Ramagopalan SV; Griesinger F; Subbiah V
    JAMA Netw Open; 2022 May; 5(5):e2214046. PubMed ID: 35612853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.
    Meguid RA; Hooker CM; Harris J; Xu L; Westra WH; Sherwood JT; Sussman M; Cattaneo SM; Shin J; Cox S; Christensen J; Prints Y; Yuan N; Zhang J; Yang SC; Brock MV
    Chest; 2010 Sep; 138(3):500-9. PubMed ID: 20507946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort.
    Slatore CG; Gould MK; Au DH; Deffebach ME; White E
    BMC Cancer; 2011 Jun; 11():228. PubMed ID: 21649915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC).
    Subramanian J; Velcheti V; Gao F; Govindan R
    J Thorac Oncol; 2007 Sep; 2(9):827-30. PubMed ID: 17805060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Duration of Immunotherapy and Overall Survival in Advanced Non-Small Cell Lung Cancer.
    Sun L; Bleiberg B; Hwang WT; Marmarelis ME; Langer CJ; Singh A; Cohen RB; Mamtani R; Aggarwal C
    JAMA Oncol; 2023 Aug; 9(8):1075-1082. PubMed ID: 37270700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.